Pathology

  • Active Grant Awards

    Dr. Ryan Askeland received a Medical Student Interest Group (MSIG) award from the Intersociety Council for Pathology Information (ICPI). This 2013 MSIG award is a useful mechanism to encourage outstanding medical students to consider a career in pathology. The award is in the amount of $1,000.

    Dr. Aaron Bossler has a new research contract negotiated with Cepheid for a research project titled Analytical Validation Study of the Cepheid Xpert BCR-ABL Monitor Assay. The contract total is $32,206. This contract is for the period of August 30, 2013 through August 30, 2014.

    Stephanie Condotta, a Post Doc Fellow in Dr. Vladimir Badovinac’s research lab, was awarded an American Heart Association, Midwest Affiliate, Winter 2013 Postdoctoral Fellowship. The title of this project is Sepsis induced changes in naïve and memory CD8 T cell responses to newly encountered infections. The award total is $95,224 and is for the period of July 1, 2013 and should be complete by June 30, 2015.

    Dr. Marina Ivanovic received one of the first small Thoracic MOG research grants at the University of Iowa. The title of this project is Metastasis-Associated Protein 1 Expression in lung adenocarcinoma. The award is in the amount of $15,000.

    Dr. Siegfried Janz received a SPORE Career Development Award through the Holden Comprehensive Cancer Center. The title of this project is Preclinical validation of the newly emerging lymphoma drug, piperlongumine (PL). This funding total is $59,874 and is for the period of September 1, 2013 and should be complete by June 30, 2014.

    Dr. Siegfried Janz received a notice of Shared Instrumentation (S10) funding from the National Institutes of Health. The title of the project is Leica LMD 7000 Laser Capture Microdissection Microscope. This award is for the period of July 1, 2013 through July 10, 2014. The amount of this award is $216,933.

    Dr. Nitin Karandikar received a notice of grant funding from the National Multiple Sclerosis Society. The title of this project is Role of CNS-Specific Autoreactive CD8+ T Cells in MS. The amount of this award is $712,800. The period for this project is April 1, 2013 through March 31, 2017.

    Dr. Nitin Karandikar received grant funding from the National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID). The title of this project is CNS-specific Regulatory CD8+ T cells in autoimmune demyelination. The total direct costs for this award are$1,125,000. The period for this project is May 1, 2011 through April 30, 2016.

    Dr. Nitin Karandikar received grant funding from National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID). The title of this project is Dissecting the Immunologic Basis of Health and Disease. The total direct costs for this award are $845,020. The period for this project is March 1, 2009 through February 28, 2014.

    Dr. C. Michael Knudson received a Donald D. Dorfman Research Award from the Holden Comprehensive Cancer Center at the University of Iowa Health Care. This award is for the best research paper in lymphoma published in 2012 or 2013. The title of the paper is 2-deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines. The award is in the amount of $2,500.

    Dr. C. Michael Knudson received funding under the Carver College of Medicine Internal Funding Opportunity for High Throughput Screening. The award is in the amount of $10,000.

    Dr. Kevin Legge received grant funding from the National Institutes of Health/National Institute of Alcohol Abuse and Alcoholism (NIH/NIAAA). The title of this project is Chronic Ethanol Consumption and Pulmonary Immune Suppression. This funding total is $396,376 and is for the period of September 5, 2013 and should be complete by August 31, 2015.

    Dr. Deqin Ma received research funding from the Carver College of Medicine, Holden Comprehensive Cancer Center at the University of Iowa. The title of this project is Molecular Studies of Leiomyosarcoma – Identification of Potential Targets for Personalized Medicine. The award is in the amount of $10,000.

    Dr. Steven Moore received funding for a study with the title of Validation of muscle biopsy histology and image analysis assays for DMD clinical study 4658-us-301. The research funding is in the amount of $56,420.

    Dr. Andrean Simons-Burnett received grant funding from the National Institutes of Health/National Institute of Dental & Craniofacial Research (NIH/NIDCR). The title of this project is Role of inflammation in resistance to EGFR inhibitors in head and neck cancer. This funding total is $1,878,808 and is for the period of July 2, 2014 and should be complete by April 30, 2019.

    Dr. Andrean Simons-Burnett received a second year of American Cancer Society Institutional Research Grant (ACS-IRG) seed grant funding from the Holden Comprehensive Cancer Center at the University of Iowa. The title of the project is Chronic ER-stress and inflammasome activity in HNSCC tumor response to EGFR inhibition. The amount of this award is $30,000. The period for this project is November 1, 2013 through October 31, 2014.